Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2001
09/19/2001EP1134292A2 Oligonucleotides for detection of vibrio parahaemolyticus and detection method for vibrio parahaemolyticus using the same oligonucleotides
09/19/2001EP1134291A1 Method for counting living cells
09/19/2001EP1134290A2 Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors
09/19/2001EP1134286A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof
09/19/2001EP1133699A1 Prevention and treatment of amyloid-associated disorders
09/19/2001EP1133697A1 Method for modifying and identifying functional sites in proteins
09/19/2001EP1133695A1 Immunostimulatory dna
09/19/2001EP1133691A2 Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device
09/19/2001EP1133689A1 Method for diagnosing neoplasia
09/19/2001EP1133575A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
09/19/2001EP1133574A1 Methods and apparatus for flow-through hybridization
09/19/2001EP1133573A2 Genotyping by mass spectrometric analysis of short dna fragments
09/19/2001EP1133572A2 Chlamydia pneumoniae genome sequence
09/19/2001EP1133571A1 Methods and compositions for pain management
09/19/2001EP1133563A2 Methods and molecules relating to cd39-like polypeptides
09/19/2001EP1133561A2 Protein fragments for use in protein targeting
09/19/2001EP1133558A1 Compositions and methods for increasing bone mineralization
09/19/2001EP1133557A2 Growth factor modulators
09/19/2001EP1133553A1 Methods using genetic package display for detecting and identifying protein-protein interactions
09/19/2001EP1133523A1 Generation of antibodies using polynucleotide vaccination in avian species
09/19/2001EP1133519A2 Functional antagonists of hedgehog activity
09/19/2001EP1133516A1 Chromosome 17p-linked prostate cancer susceptibility gene
09/19/2001EP1133515A1 Dna molecules encoding hg51, a g-protein-coupled receptor
09/19/2001EP1133514A1 Method for the electrochemical detection of nucleic acid oligomer hybrids
09/19/2001EP1133513A1 Multidomain polynucleotide molecular sensors
09/19/2001EP1133310A2 Artery- and vein-specific proteins and uses therefor
09/19/2001EP1133294A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
09/19/2001EP1108212A4 Methods and materials for diagnosing unstable angina
09/19/2001EP1105517A4 Rapid quantitative analysis of proteins or protein function in complex mixtures
09/19/2001EP1092041A4 Exonuclease-mediated nucleic acid reassembly in directed evolution
09/19/2001EP0981609B1 A method to clone mrnas and display of differentially expressed transcripts (dodet)
09/19/2001EP0876509B1 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
09/19/2001EP0820522B1 Assays and devices for the detection of extrahepatic biliary atresia
09/19/2001EP0802986B1 Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods
09/19/2001EP0789540B1 Analyte-controlled liquid delivery device and analyte monitor
09/19/2001EP0649417B1 Improved chemiluminescent 1,2-dioxetanes
09/19/2001CN1313908A Assays using crosslinkable immobilized nucleic acids
09/19/2001CN1313907A Process for preparing peptide nucleic acid probe using polymeric photoacid generator
09/19/2001CN1313906A Single nucleotide polymorphic discrimination by electronic dot blot assay on semiconductor microchips
09/19/2001CN1313901A Novel human lysozyme gene, its encoding polypeptide and the method for preparing them
09/19/2001CN1313897A New gene of humanlysoenzyme, the encoding polypeptide and methods for preparing them
09/19/2001CN1313893A FY7 polymerase
09/19/2001CN1313891A Methods of monitoring disease states and therapies using gene expression profiles
09/19/2001CN1313864A Particles of HCV envelope proteins use of vaccination
09/19/2001CN1313404A Molecular amplification in biochip test
09/19/2001CN1313401A Polypeptide-human space I enzyme 11 and polynucleotide for coding it
09/19/2001CN1313393A Polypeptide-human RNA unwindase 13 and polynucleotide for coding it
09/19/2001CN1313342A Human testis lactate dehydrogenase A gene coded protein
09/19/2001CN1313341A Human testis protein kinase gene coded protein
09/19/2001CN1313340A Human sperm-specific protein 2 gene coded protein
09/19/2001CN1313339A Human sperm binding gene coded protein
09/19/2001CN1313338A Polypeptide motif bound with human CD95 and its polypeptide
09/19/2001CN1313130A Application of RIZ gene in detecting and treating tumor showing MSI positive
09/19/2001CN1071454C Immunoassay of products and detection of chemicals by immunoassay
09/18/2001US6291742 Genetically engineering plants to produce seeds having a kappa hydroxylase construct integrated into its genome;increasing the amount of hydroxylated fatty acyl compound in the seeds
09/18/2001US6291664 Method of eliminating inhibitory/instability regions of mRNA
09/18/2001US6291663 TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
09/18/2001US6291658 Isolated nucleic acid molecules encoding SSX family members and thereof
09/18/2001US6291641 Hepatitis E virus antigens and uses therefor
09/18/2001US6291637 Peptide modulator of protein biosynthesis; for utilization as viricide
09/18/2001US6291430 Mage-3 peptides presented by HLA class II molecules
09/18/2001US6291242 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
09/18/2001US6291237 Cancer diagnosis and therapy based on mutations in TGF-β receptors
09/18/2001US6291236 Human cytomegalovirus DNA sequences
09/18/2001US6291227 Nucleotide sequences coding viral polypeptides; for use in the development of vaccines which prevent retroviral infections
09/18/2001US6291218 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use
09/18/2001US6291217 Glutathionylspermidine synthetase and processes for recovery and use thereof
09/18/2001US6291213 Generating genetically engineered nucleotide sequences; incubate primers with nucleotide sequences, amplify sequences, denature products, incubate and amplify single-stranded products, recover amplified products
09/18/2001US6291201 Fluorescence energy transfer substrates
09/18/2001US6291200 Enzyme-containing polymeric sensors
09/18/2001US6291197 Binding moieties for human parvovirus B19
09/18/2001US6291195 Generating ligands which bind preferential human receptors; incubate cells expressing preferential binding protein with modulator, detect adjustment in binding activity
09/18/2001US6291194 Assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound
09/18/2001US6291192 Method for identifying conditions that facilitate recombinant protein folding
09/18/2001US6291191 Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization
09/18/2001US6291190 Molecular differences between species of the M. tuberculosis complex
09/18/2001US6291188 Metallic solid supports modified with nucleic acids
09/18/2001US6291187 Detecting target dna by selective amplification of linear sequences or rolling circle amplification while improving sensitivity by using additional stages or platforms and poly-primer mixtures for exponential amplification
09/18/2001US6291186 Method for screening for unknown organisms
09/18/2001US6291185 Electrochemical denaturation of double-stranded nucleic acid
09/18/2001US6291184 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
09/18/2001US6291183 A plurality of oligonucleotide linker molecules are attached on a planar solid support, photoremovable groups react with terminal ends of oligonucleotides, substrates exposed to light activate binding at selected areas; peptide synthesis
09/18/2001US6291182 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
09/18/2001US6291181 Isolate target nucleic acids having undetermined nucleotides by ligating the nucleic acid to adapters having type iis endonuclease recognition sequence within the adapters; capture, determine sequences adjacent to restriction sites
09/18/2001US6291179 Product and method for separation of a sample containing multiple sources of genetic material using a solid medium
09/18/2001US6291178 A kit containing an ionic solute that when diluted creates a solution with an isomolality of normal physiological body fliud and an enzymatic inhibitor; saliva sample is collected into a specimen cup and sealed that is tampered resistant
09/18/2001US6291177 Contacting transformed yeast cells responsive to g-protein coupled activation of yeast protein containing a selected promoter; detecting levels of a second messenger of mammalian g-protein coupled receptor activation of the yeast protein
09/18/2001US6291176 Identification of a DNA region potentially useful for the detection of mycobacterium kansasii
09/18/2001US6291175 Methods for treating a neurological disease by determining BCHE genotype
09/18/2001US6291174 Screening detection method to determine the presence of follicle-stimulating hormone beta subunit allele in pig genomes; for improving pig litter sizes
09/18/2001US6291172 Diagnostic assay for diabetes mellitus based on mutational burden
09/18/2001US6291170 Complementary deoxyribonucleic acid is synthesized by rna using a complementary primer linked to a rna polymerase promoter, anti-sense rna is transcribed from the cdna when rna polymerase binds the promoter region; diagnosis/forensic
09/18/2001US6291169 Hapten derivatized capture membrane and diagnostic assays using such membrane
09/18/2001US6291168 Nucleic acid sequences diagnostic for pathogenic E.coli O157:H7, methods of identification and kit therefore
09/18/2001US6291167 Method for determining the existence of a mutation
09/18/2001US6291166 Irreversibly capturing rna or dna using highly electropositive solid phases matrices, as a means for aqueous washes, buffer changes and volume reduction during procedure; for direct analysis of single or double stranded nucleic acid
09/18/2001US6291165 Shuffling of heterologous DNA sequences
09/18/2001US6291164 Methods for preventing inhibition of nucleic acid synthesis by pyrophosphate
09/18/2001US6291163 Dectecting for cancer by amplifying sample dna at a genetic locus containg microsatellite dna, detecting an allelic imbalance by comparing levels of microsatellite dna present at the first and second alleles
09/18/2001US6291162 Determining amount of lactamase activity; transfecting cells with a nucleic acid having an expression control sequence linked to a secretion defective sequence; mixing cells with lactamase substrate; determine amount of cleaved substrate